Literature DB >> 23717031

Selective Elevation of Antibodies to Desmoglein 1 during the Transition from Mucocutaneous to Cutaneous Type Pemphigus Vulgaris.

Haruna Matsuda-Hirose1, Kazushi Ishikawa, Mizuki Goto, Yutaka Hatano, Sakuhei Fujiwara.   

Abstract

Entities:  

Year:  2013        PMID： 23717031      PMCID： PMC3662933          DOI： 10.5021/ad.2013.25.2.263

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN： 1013-9087            Impact factor:   1.444


× No keyword cloud information.
  5 in total

1.  Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles.

Authors:  X Ding; V Aoki; J M Mascaro; A Lopez-Swiderski; L A Diaz; J A Fairley
Journal:  J Invest Dermatol       Date:  1997-10       Impact factor: 8.551

2.  Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy.

Authors:  R J Feldman; W G Christen; A R Ahmed
Journal:  Br J Dermatol       Date:  2012-01-19       Impact factor: 9.302

3.  Cutaneous type pemphigus vulgaris: a rare clinical phenotype of pemphigus.

Authors:  Kazue Yoshida; Yujiro Takae; Hitoshi Saito; Hiroshi Oka; Akiko Tanikawa; Masayuki Amagai; Takeji Nishikawa
Journal:  J Am Acad Dermatol       Date:  2005-05       Impact factor: 11.527

4.  Efficacy and safety of rituximab treatment in Indian pemphigus patients.

Authors:  A J Kanwar; D Tsuruta; K Vinay; H Koga; N Ishii; T Dainichi; T Hashimoto
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-12-17       Impact factor: 6.166

Review 5.  Cutaneous pemphigus vulgaris with skin features similar to the classic mucocutaneous type: a case report and review of the literature.

Authors:  S Shinkuma; W Nishie; A Shibaki; D Sawamura; K Ito; Y Tsuji-Abe; K Natsuga; P T Chan; M Amagai; H Shimizu
Journal:  Clin Exp Dermatol       Date:  2008-07-04       Impact factor: 3.470
  5 in total
  1 in total

1.  A Case of Pemphigus Herpetiformis with Only Immunoglobulin G Anti-Desmocollin 3 Antibodies.

Authors:  Won Jin Hong; Takashi Hashimoto; Soo-Chan Kim
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.